Literature DB >> 21133813

Cytokine/stromal cell networks and lymphoid tissue environments.

Jörg H Fritz1, Jennifer L Gommerman.   

Abstract

Initiation of an effective adaptive immune response against a foreign pathogen requires orchestrated encounters between lymphocytes and antigen-presenting cells. The tissues of the lymphoid system provide the ideal environment for increasing the efficiency of these encounters. Within the spleen, the mucosal-associated lymphoid tissues, and the lymph nodes, an intricate network of stromal cells, collagen fibers, and extracellular matrix exists that effectively compartmentalizes immune cells as they transit through these tissues. The stromal cells within lymphoid tissues are by no means homogenous, and it is now clear that these cells are not merely sessile bystanders during immune responses. Indeed, stromal cells within lymphoid tissues are the source of important cytokines and chemokines that guide and polarize immune cells. Here, we review the cytokines that maintain the integrity of this important stromal scaffold system within the lymphoid tissue, paying particular attention to the Lymphotoxin pathway, which is an important player in stromal cell biology. How cytokines maintain the organization of lymphoid tissues during development, in the adult animal, during inflammation and during disease will be discussed in sequence, and the clinical implications of targeting cytokines that regulate lymphoid tissue stroma will be considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21133813     DOI: 10.1089/jir.2010.0121

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  10 in total

1.  Lymph node choreography: B cells take the lead.

Authors:  Jennifer L Cannons; Kristina T Lu; Pamela L Schwartzberg
Journal:  Nat Immunol       Date:  2012-06-19       Impact factor: 25.606

2.  Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts.

Authors:  Y Nakayama; J S Bromberg
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

3.  Unusual timing of CD127 expression by mouse uterine natural killer cells.

Authors:  Jianhong Zhang; Zhilin Chen; Jörg H Fritz; Yrina Rochman; Warren J Leonard; Jennifer L Gommerman; Adam W Plumb; Ninan Abraham; B Anne Croy
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

Review 4.  Fine-tuning of dendritic cell biology by the TNF superfamily.

Authors:  Leslie Summers deLuca; Jennifer L Gommerman
Journal:  Nat Rev Immunol       Date:  2012-04-10       Impact factor: 53.106

Review 5.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

6.  Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration.

Authors:  C Colin Brinkman; Daiki Iwami; Molly K Hritzo; Yanbao Xiong; Sarwat Ahmad; Thomas Simon; Keli L Hippen; Bruce R Blazar; Jonathan S Bromberg
Journal:  Nat Commun       Date:  2016-06-21       Impact factor: 14.919

7.  Staphylococcus epidermidis Biofilm-Released Cells Induce a Prompt and More Marked In vivo Inflammatory-Type Response than Planktonic or Biofilm Cells.

Authors:  Angela França; Begoña Pérez-Cabezas; Alexandra Correia; Gerald B Pier; Nuno Cerca; Manuel Vilanova
Journal:  Front Microbiol       Date:  2016-09-27       Impact factor: 5.640

8.  Emerging Functions of RANKL in Lymphoid Tissues.

Authors:  Christopher G Mueller; Estelle Hess
Journal:  Front Immunol       Date:  2012-09-03       Impact factor: 7.561

Review 9.  Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues.

Authors:  Theresa T Lu; Jeffrey L Browning
Journal:  Front Immunol       Date:  2014-02-11       Impact factor: 7.561

10.  Emerging immune functions of non-hematopoietic stromal cells.

Authors:  Christopher G Mueller; Mark Christopher Coles
Journal:  Front Immunol       Date:  2014-09-12       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.